However, their anti-inflammatory activity, including inhibition of cyclooxygenases 1 and 2 (COX-1, -2), resulting in a reduction of several prostaglandins (PGs) as well as thromboxane A, are recognized as potential anti-cancer mechanisms [4,5]. This evidence concerns the gene PTGS1 and cancer.